(Q34075138)

30 July 2017

1 reference

title

An evaluation of intrathecal ziconotide for the treatment of chronic pain (English)

1 reference

30 July 2017

0 references

K K Jain

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

2403-2410

1 reference

Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2403

A novel omega-conopeptide for the presynaptic localization of calcium channels at the mammalian neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2403

Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2403

Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2403

Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2403

Ziconotide for the treatment of severe spasticity after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2403

10.1517/13543784.9.10.2403

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference